Institutional investors purchased a net $958.3 thousand shares of CCXI during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 58.48% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SIMPLEX TRADING LLC Sold 384.00 shares of ChemoCentryx Inc
TOWER RESEARCH CAPITAL LLC Sold 781.00 shares of ChemoCentryx Inc
NATIONWIDE FUND ADVISORS Sold 1.4 Thousand shares of ChemoCentryx Inc